These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30024940)

  • 1. Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.
    Roosenhoff R; van der Vries E; van der Linden A; van Amerongen G; Stittelaar KJ; Smits SL; Schutten M; Fouchier RAM
    PLoS One; 2018; 13(7):e0200849. PubMed ID: 30024940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
    J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.
    Piralla A; Gozalo-Margüello M; Fiorina L; Rovida F; Muzzi A; Colombo AA; Alessandrino PE; Baldanti F
    J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
    Oh DY; Panozzo J; Vitesnik S; Farrukee R; Piedrafita D; Mosse J; Hurt AC
    Antivir Ther; 2018; 23(4):295-306. PubMed ID: 28195559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
    Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
    BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.
    van der Vries E; Stittelaar KJ; van Amerongen G; Veldhuis Kroeze EJ; de Waal L; Fraaij PL; Meesters RJ; Luider TM; van der Nagel B; Koch B; Vulto AG; Schutten M; Osterhaus AD
    PLoS Pathog; 2013; 9(5):e1003343. PubMed ID: 23717200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple influenza A (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient.
    Eshaghi A; Shalhoub S; Rosenfeld P; Li A; Higgins RR; Stogios PJ; Savchenko A; Bastien N; Li Y; Rotstein C; Gubbay JB
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7188-97. PubMed ID: 25246391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
    Hurt AC; Nor'e SS; McCaw JM; Fryer HR; Mosse J; McLean AR; Barr IG
    J Virol; 2010 Sep; 84(18):9427-38. PubMed ID: 20631138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.
    Memoli MJ; Hrabal RJ; Hassantoufighi A; Jagger BW; Sheng ZM; Eichelberger MC; Taubenberger JK
    J Infect Dis; 2010 May; 201(9):1397-403. PubMed ID: 20350163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a transient R292K mutation in influenza A/H3N2 viruses shed for several weeks by an immunocompromised patient.
    Babady NE; Laplante JM; Tang YW; St George K
    J Clin Microbiol; 2015 Apr; 53(4):1415-8. PubMed ID: 25588658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.
    Herlocher ML; Truscon R; Elias S; Yen HL; Roberts NA; Ohmit SE; Monto AS
    J Infect Dis; 2004 Nov; 190(9):1627-30. PubMed ID: 15478068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model.
    Koszalka P; George A; Dhanasekaran V; Hurt AC; Subbarao K
    mBio; 2022 Aug; 13(4):e0105622. PubMed ID: 35938724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
    Tilmanis D; Koszalka P; Barr IG; Rossignol JF; Mifsud E; Hurt AC
    Antiviral Res; 2020 Aug; 180():104851. PubMed ID: 32544408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.
    Sato M; Honzumi K; Sato T; Hashimoto K; Watanabe M; Miyazaki K; Kawasaki Y; Hosoya M
    J Clin Virol; 2015 Jul; 68():97-103. PubMed ID: 26071346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS).
    Roosenhoff R; Schutten M; Reed V; Clinch B; van der Linden A; Fouchier RAM; Fraaij PLA
    Antiviral Res; 2021 May; 189():105060. PubMed ID: 33713731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.
    Marjuki H; Mishin VP; Chesnokov AP; Jones J; De La Cruz JA; Sleeman K; Tamura D; Nguyen HT; Wu HS; Chang FY; Liu MT; Fry AM; Cox NJ; Villanueva JM; Davis CT; Gubareva LV
    J Infect Dis; 2015 Jan; 211(2):249-57. PubMed ID: 25124927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient.
    Pontoriero A; Avaro M; Benedetti E; Russo M; Czech A; Periolo N; Campos A; Zamora A; Baumeister E
    Mem Inst Oswaldo Cruz; 2016 Dec; 111(12):745-749. PubMed ID: 27849220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.
    Lina B; Boucher C; Osterhaus A; Monto AS; Schutten M; Whitley RJ; Nguyen-Van-Tam JS
    Influenza Other Respir Viruses; 2018 Mar; 12(2):267-278. PubMed ID: 29265727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
    Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.